Mesenchymal stromal cells and kidney transplantation: pretransplant infusion protects from graft dysfunction while fostering immunoregulation.
about
Transplant Tolerance Induction in Newborn Infants: Mechanisms, Advantages, and Potential StrategiesMesenchymal stem cells and immunomodulation: current status and future prospectsMesenchymal stromal cell therapy in liver disease: opportunities and lessons to be learnt?Safety and Efficacy Endpoints for Mesenchymal Stromal Cell Therapy in Renal Transplant RecipientsAdult stem cells in neural repair: Current options, limitations and perspectivesMesenchymal stem cell-based therapy in kidney transplantationMesenchymal Stem Cell-Based Therapy for Kidney Disease: A Review of Clinical EvidenceTargeting Endogenous Repair Pathways after AKI.Effects of heme oxygenase-1-modified bone marrow mesenchymal stem cells on microcirculation and energy metabolism following liver transplantation.Clinical-Grade Isolated Human Kidney Perivascular Stromal Cells as an Organotypic Cell Source for Kidney Regenerative Medicine.Reduction of acute rejection by bone marrow mesenchymal stem cells during rat small bowel transplantation.Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipientsMesenchymal stromal (stem) cells to improve solid organ transplant outcome: lessons from the initial clinical trials.Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune study.Heme oxygenase-1-transduced bone marrow mesenchymal stem cells in reducing acute rejection and improving small bowel transplantation outcomes in ratsImmunomodulatory effects of OX40Ig gene-modified adipose tissue-derived mesenchymal stem cells on rat kidney transplantationInterferon-gamma modification of mesenchymal stem cells: implications of autologous and allogeneic mesenchymal stem cell therapy in allotransplantation.Mesenchymal stromal cell therapy in conditions of renal ischaemia/reperfusion.Report of the joint ESOT and TTS basic science meeting 2013: current concepts and discoveries in translational transplantation.Caveats of mesenchymal stem cell therapy in solid organ transplantation.Strategies to optimize kidney recovery and preservation in transplantation: specific aspects in pediatric transplantation.Rationale for the potential use of mesenchymal stromal cells in liver transplantation.Hypothermic machine perfusion of kidneys retrieved from standard and high-risk donors.The exciting "bench to bedside" journey of cell therapies for acute kidney injury and renal transplantation.Human Allogeneic Bone Marrow and Adipose Tissue Derived Mesenchymal Stromal Cells Induce CD8+ Cytotoxic T Cell Reactivity.Mesenchymal stromal cells in renal transplantation: opportunities and challenges.Mesenchymal stromal cell therapy for the treatment of intestinal ischemia: Defining the optimal cell isolate for maximum therapeutic benefit.Cell therapeutic approaches to immunosuppression after clinical kidney transplantation.Micro-vesicles derived from bone marrow stem cells protect the kidney both in vivo and in vitro by microRNA-dependent repairing.Adoptive cell transfer in autoimmune hepatitis.Mesenchymal stem cells and their immunosuppressive role in transplantation tolerance.TLR3 or TLR4 Activation Enhances Mesenchymal Stromal Cell-Mediated Treg Induction via Notch Signaling.NK Cells and MSCs: Possible Implications for MSC Therapy in Renal Transplantation.Safety and Tolerance of Donor-Derived Mesenchymal Stem Cells in Pediatric Living-Donor Liver Transplantation: The MYSTEP1 Study.Involvement of PI3K and MMP1 in PDGF-induced Migration of Human Adipose-derived Stem Cells.Recent Progress in Cell Therapy in Solid Organ Transplantation.Administration of mesenchymal stromal cells before renal ischemia/reperfusion attenuates kidney injury and may modulate renal lipid metabolism in ratsMesenchymal Stem Cells Deliver Exogenous MicroRNA-let7c via Exosomes to Attenuate Renal FibrosisA Novel Clinical Grade Isolation Method for Human Kidney Perivascular Stromal CellsMaximising impact of small cohort studies.
P2860
Q26752512-2F95CCE8-65F4-4C3A-9017-AE12A6716D27Q26770191-513D9A05-051A-4857-A206-7C365F91DD7EQ26796475-8A54ABA6-DD65-4776-A599-0EDE9D25F30CQ26799916-6D92AB6A-6A20-436F-9E9E-51F88DDF1002Q26824821-221F267B-6108-451B-82F6-51F9AE32000AQ28069543-9E4128E9-6056-40A5-9CA7-C8EF06B7E548Q28079089-42E58B8B-96FA-4BCE-BD25-F8FDD87CAAE8Q30278062-489CF97F-A6E2-430E-B370-6FDAEA80B89CQ33719955-156D4F5C-BE20-41CF-AF34-97EF74BDD33BQ33722487-2EBCC0C0-596F-4C27-9EB2-9E598C94FAA8Q34702762-FB60396B-0847-43EA-A1DA-655DAFFBC284Q34753440-2BC7DC98-0D52-44FD-BF06-5CBEB80329CFQ35344810-447C542C-CCED-4EAB-A6DF-997CA9A79DADQ36246918-2520697E-A2F8-4D4A-8DCF-2E58411E7807Q37424307-2EDE860C-086D-4FF5-B444-ABC21238AF84Q37527784-F358C23E-9A54-4A6B-9CF7-507C3FDEAF75Q38186634-E0FCE06F-12BD-4270-939A-B3BA933B6605Q38187110-DCF5AD4C-A2C1-4D86-BC64-78B00C655EEEQ38217077-FB92890D-EBE9-43BB-BA68-213A5B01639CQ38235872-DEA9DD8A-6817-44B1-B18F-9B4F4E881523Q38245855-42084ADC-E846-4947-8DD3-D9251746BF7AQ38282065-3103343F-75BE-4D90-87F4-8C26DBEE9153Q38335659-1D31C471-8F81-4955-82C0-8B9C0A76597DQ38558079-8BEEBBFE-3C22-41BA-85AB-5C27B9789D5EQ38688638-FFFD5607-53AF-45B5-A1EF-A58415B9976BQ38725481-B37E8404-83CF-4C69-AE39-45DF2807A378Q38733373-E3F7DB02-CE07-4E21-B2B5-7BEC1B166544Q38754342-A51F4E03-8BA6-458F-88F7-C0D7DFD953D0Q38883093-C441544F-F972-4BFB-AE87-1E0F1263109DQ39035161-4F573897-5317-4F28-B142-D0B49070EA23Q39430866-27392039-6957-4C95-A8DC-F4707070B5CFQ39443690-CB67E1F4-DE09-4835-9E51-9A667C25D07AQ40133843-61E73F25-E2BF-4B9F-9BA8-91A8E424CF57Q40979801-CD11D385-2BD9-49D4-BEEE-CEC3B23839CFQ41159338-E71F5B7B-FBD5-442E-8C6C-17F6481CE0D9Q41444299-400C01AE-4DFF-4560-B3A6-FC7F6A76CB8BQ41447058-EC76256C-DE09-45CC-906A-4F9BBAA23845Q41635867-73FF694B-F2C1-4A13-A074-155090972CC8Q42364183-FDA7E734-E4E0-46BB-B92B-1288F8AF4AC1Q44477333-5B3A6DC8-5F11-4CF3-9D0C-DA3EFA471DA2
P2860
Mesenchymal stromal cells and kidney transplantation: pretransplant infusion protects from graft dysfunction while fostering immunoregulation.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Mesenchymal stromal cells and ...... le fostering immunoregulation.
@en
Mesenchymal stromal cells and ...... le fostering immunoregulation.
@nl
type
label
Mesenchymal stromal cells and ...... le fostering immunoregulation.
@en
Mesenchymal stromal cells and ...... le fostering immunoregulation.
@nl
prefLabel
Mesenchymal stromal cells and ...... le fostering immunoregulation.
@en
Mesenchymal stromal cells and ...... le fostering immunoregulation.
@nl
P2093
P2860
P50
P356
P1476
Mesenchymal stromal cells and ...... ile fostering immunoregulation
@en
P2093
Alessandro Rambaldi
Chiara Capelli
Eliana Gotti
Marina Noris
Marta Todeschini
Norberto Perico
Paola Cassis
Paola Rizzo
Regiane Aparecida Cavinato
P2860
P304
P356
10.1111/TRI.12132
P577
2013-06-06T00:00:00Z